NCT04073121View on ClinicalTrials.gov

Investigating the Safety and Efficacy of the Treatment With Luminor DCB and Angiolite DES of iVascular in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 27, 2018

Primary Completion Date

March 10, 2020

Study Completion Date

September 30, 2020

Conditions
Critical Limb Ischemia
Interventions
DEVICE

Luminor DCB and Angiolite DES

Patient to undergo angioplasty with Luminor DCB and Angiolite DES

Trial Locations (2)

169608

Singapore General Hospital, Singapore

768828

Khoo Teck Puat Hospital, Singapore

All Listed Sponsors
lead

Singapore General Hospital

OTHER

NCT04073121 - Investigating the Safety and Efficacy of the Treatment With Luminor DCB and Angiolite DES of iVascular in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia | Biotech Hunter | Biotech Hunter